These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 29476657)
1. Medawar's "actively acquired tolerance" and the Danger model: Setting the record straight. Al-Yassin G Scand J Immunol; 2018 Sep; 88(3):e12652. PubMed ID: 29476657 [TBL] [Abstract][Full Text] [Related]
2. Medawar's legacy to cellular immunology and clinical transplantation: a commentary on Billingham, Brent and Medawar (1956) 'Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance'. Simpson E Philos Trans R Soc Lond B Biol Sci; 2015 Apr; 370(1666):. PubMed ID: 25750245 [TBL] [Abstract][Full Text] [Related]
3. Medawar and Hamilton on the selective forces in the evolution of ageing. Giaimo S Hist Philos Life Sci; 2021 Nov; 43(4):124. PubMed ID: 34822012 [TBL] [Abstract][Full Text] [Related]
4. The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self-reactive T cells? Manjili MH Scand J Immunol; 2022 Oct; 96(4):e13209. PubMed ID: 36239215 [TBL] [Abstract][Full Text] [Related]
5. Molecular pattern recognition in peripheral B cell tolerance: lessons from age-associated B cells. Johnson JL; Scholz JL; Marshak-Rothstein A; Cancro MP Curr Opin Immunol; 2019 Dec; 61():33-38. PubMed ID: 31446338 [TBL] [Abstract][Full Text] [Related]
6. Does the Danger model shed any light on central tolerance?: A response to Al-Yassin. Fuchs EJ; Matzinger P Scand J Immunol; 2018 Sep; 88(3):e12660. PubMed ID: 29542175 [No Abstract] [Full Text] [Related]
7. On Medawar's 'Actively acquired tolerance of foreign cells'. Tolar J; Tolarova S; McGrath JA Exp Dermatol; 2014 Feb; 23(2):97-8. PubMed ID: 24476006 [TBL] [Abstract][Full Text] [Related]
14. On certain two-signal perspectives of lymphocyte activation and inactivation, thymic G-quadruplexes, and the role of aggregation in self/not-self discrimination. Forsdyke DR Scand J Immunol; 2019 Oct; 90(4):e12797. PubMed ID: 31166602 [TBL] [Abstract][Full Text] [Related]
15. Questions of Stochasticity and Control in Immune Repertoires. Yaari G; Flajnik M; Hershberg U Trends Immunol; 2018 Nov; 39(11):859-861. PubMed ID: 30243818 [No Abstract] [Full Text] [Related]
16. Evolution of immune systems from self/not self to danger to artificial immune systems (AIS). Cooper EL Phys Life Rev; 2010 Mar; 7(1):55-78. PubMed ID: 20374928 [TBL] [Abstract][Full Text] [Related]
17. The danger model in deciphering autoimmunity. Tveita AA Rheumatology (Oxford); 2010 Apr; 49(4):632-9. PubMed ID: 20144928 [TBL] [Abstract][Full Text] [Related]
18. 'The shape of the human being as a function of time': time, transplantation, and tolerance in Peter Brian Medawar's research, 1937-1956. Park HW Endeavour; 2010 Sep; 34(3):112-21. PubMed ID: 20692038 [TBL] [Abstract][Full Text] [Related]
19. The curious case of the 1960 Nobel Prize to Burnet and Medawar. Silverstein AM Immunology; 2016 Mar; 147(3):269-74. PubMed ID: 26790994 [TBL] [Abstract][Full Text] [Related]
20. The real "danger" lies in the failure to confront fundamentals. Cohn M Scand J Immunol; 2018 Dec; 88(6):e12726. PubMed ID: 30311672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]